Compounds > nifedipine

nifedipine and zeneca zd 6169

nifedipine has been researched along with zeneca zd 6169 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Ikawa, S; Ito, Y; Naito, S; Seki, N; Takano, N; Tanaka, K; Teramoto, N; Yunoki, T1
Brioni, JD; Brune, ME; Carroll, WA; Coghlan, MJ; Fey, TA; Gopalakrishnan, M; Sullivan, JP; Williams, M1
Calzadilla, SV; Cox, BF; Fryer, RM; Gopalakrishnan, M; Hu, Y; Lin, CT; Marsh, KC; Preusser, LC; Reinhart, GA; Xu, H1

Other Studies

4 other study(ies) available for nifedipine and zeneca zd 6169

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
The involvement of L-type Ca(2+) channels in the relaxant effects of the ATP-sensitive K(+) channel opener ZD6169 on pig urethral smooth muscle.
    British journal of pharmacology, 2001, Volume: 134, Issue:7

    Topics: Adenosine Triphosphate; Amides; Animals; Barium; Benzophenones; Calcium Channel Blockers; Calcium Channels, L-Type; Dose-Response Relationship, Drug; Electric Stimulation; Female; Gene Expression; Glyburide; In Vitro Techniques; Membrane Potentials; Muscle Relaxation; Muscle, Smooth; Nifedipine; Potassium Channels; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swine; Urethra

2001
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. II. in vivo characterization.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1

    Topics: Amides; Animals; ATP-Binding Cassette Transporters; Benzophenones; Cyclic S-Oxides; Cyclobutanes; Ion Channel Gating; KATP Channels; Muscle Contraction; Muscle, Smooth; Nifedipine; Nitriles; Potassium Channels; Potassium Channels, Inwardly Rectifying; Quinolones; Swine; Urinary Bladder

2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canine.
    Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:2

    Topics: Adenosine Triphosphate; Amides; Animals; Benzophenones; Blood Pressure; Cyclic S-Oxides; Cyclobutanes; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; Heart Rate; Hypotension; Infusions, Intravenous; Ion Channel Gating; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Nitriles; Pharmaceutical Vehicles; Polyethylene Glycols; Potassium Channels; Quinolones; Tachycardia; Urinary Bladder; Urinary Incontinence; Vascular Resistance

2004